334 related articles for article (PubMed ID: 7534855)
1. CD44 variant exon epitopes in primary breast cancer and length of survival.
Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
[TBL] [Abstract][Full Text] [Related]
2. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
[TBL] [Abstract][Full Text] [Related]
3. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
4. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44.
Sinn HP; Heider KH; Skroch-Angel P; von Minckwitz G; Kaufmann M; Herrlich P; Ponta H
Breast Cancer Res Treat; 1995; 36(3):307-313. PubMed ID: 8573713
[TBL] [Abstract][Full Text] [Related]
5. Patterns of splice variant CD44 expression by normal human urothelium in situ and in vitro and by bladder-carcinoma cell lines.
Southgate J; Trejdosiewicz LK; Smith B; Selby PJ
Int J Cancer; 1995 Aug; 62(4):449-56. PubMed ID: 7543458
[TBL] [Abstract][Full Text] [Related]
6. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
7. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer.
Schumacher U; Horny HP; Horst HA; Herrlich P; Kaiserling E
Eur J Surg Oncol; 1996 Jun; 22(3):259-61. PubMed ID: 8654608
[TBL] [Abstract][Full Text] [Related]
8. CD44 isoforms in prognosis of breast cancer.
Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
Lancet; 1995 Aug; 346(8973):502. PubMed ID: 7543643
[No Abstract] [Full Text] [Related]
9. The expression of variant exon v7-v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer.
Kinoshita J; Haga S; Shimizu T; Imamura H; Watanabe O; Kajiwara T
Breast Cancer Res Treat; 1999 Jan; 53(2):177-83. PubMed ID: 10326795
[TBL] [Abstract][Full Text] [Related]
10. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of CD44 variant expression in primary breast cancer.
Foekens JA; Dall P; Klijn JG; Skroch-Angel P; Claassen CJ; Look MP; Ponta H; Van Putten WL; Herrlich P; Henzen-Logmans SC
Int J Cancer; 1999 Jun; 84(3):209-15. PubMed ID: 10371335
[TBL] [Abstract][Full Text] [Related]
13. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
Dall P; Heider KH; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
Cancer Res; 1994 Jul; 54(13):3337-41. PubMed ID: 7516819
[TBL] [Abstract][Full Text] [Related]
14. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.
Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S
J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265
[TBL] [Abstract][Full Text] [Related]
15. Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma.
Hong RL; Pu YS; Chu JS; Lee WJ; Chen YC; Wu CW
Cancer Lett; 1995 Feb; 89(1):81-7. PubMed ID: 7533658
[TBL] [Abstract][Full Text] [Related]
16. Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas.
Jackson DG; Schenker T; Waibel R; Bell JI; Stahel RA
Int J Cancer Suppl; 1994; 8():110-5. PubMed ID: 7515025
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 variant exons 8-10 in colorectal cancer and its relationship to metastasis.
Takeuchi K; Yamaguchi A; Urano T; Goi T; Nakagawara G; Shiku H
Jpn J Cancer Res; 1995 Mar; 86(3):292-7. PubMed ID: 7538103
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease.
Rosenberg WM; Prince C; Kaklamanis L; Fox SB; Jackson DG; Simmons DL; Chapman RW; Trowell JM; Jewell DP; Bell JI
Lancet; 1995 May; 345(8959):1205-9. PubMed ID: 7537840
[TBL] [Abstract][Full Text] [Related]
20. CD44 isoforms in prognosis of breast cancer.
Friedrichs K; Kügler G; Franke F; Terpe HJ; Arlt J; Regidor PA; Günthert U
Lancet; 1995 May; 345(8959):1237. PubMed ID: 7537842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
